跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zavedos - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zavedos
Approved
STANDARD
Zavedos
Corden Pharma Latina S.p.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
176ce04909da7d34
Company
Corden Pharma Latina S.p.A.
Type
Standard
Approval Details
Approval Id
176ce04909da7d34
Drug Approval Philippines Name
Zavedos
Product Name
Zavedos
Registration Number
DR-XY15884
Brand Name
Zavedos
Generic Name
Idarubicin Hydrochloride
Dosage Form
Lyophilized Powder for IV Injection
Dosage Strength
5 mg
Manufacturer
Corden Pharma Latina S.p.A.
Trader
Pfizer, Inc.
Importer
Pfizer, Inc.
Distributor
Pfizer, Inc.
Company Detail Path
/organization/corden-pharma-latina-spa
Trader Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Distributor Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
31 July 2023
Expiry Date
31 July 2028
Pharmacologic Category
Antineoplastic (Anthracycline and related substance)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
176ce04909da7d34
Type
Standard
Back to Philippines FDA Approvals